About Careers MedBlog Contact us

Risk Of Outcomes Ruled-Out For Measles Vaccines

by Julia Samuel on January 9, 2015 at 1:53 PM
Font : A-A+

Risk Of Outcomes Ruled-Out For Measles Vaccines

Seizure, fever, and immune thrombocytopenia purpura (ITP) are the types of adverse events associated with vaccines for measles.

An investigation was done to check whether the measles-mumps-rubella-varicella (MMRV) is riskier than the separate measles-mumps-rubella (MMR) and varicella (MMR + V) and if it elevates the risk for additional safety outcomes.


Study children were aged 12 to 23 months in the Vaccine Safety Datalink from 2000 to 2012. The number of doses evaluated for MMRV was 123 200 and 584 987 for MMR + V respectively.

Seven outcomes (anaphylaxis, ITP, ataxia, arthritis, meningitis/encephalitis, acute disseminated encephalomyelitis, and Kawasaki disease) were analysed and compared with the vaccines.

There was no significant difference between MMRV with MMR + V as the outcomes had few or zero post vaccination events.

The study did not identify any new safety concerns comparing MMRV with MMR + V or after either the MMRV or the MMR + V vaccine.

The study reassures that these outcomes are unlikely after either vaccine.

Source: Medindia

Recommended Reading

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Risk Of Outcomes Ruled-Out For Measles Vaccines Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests